Evidence map›Paper›PMID 42544995›Full record

ArticleApplied and environmental microbiology2026

Rhamnolipid-augmented medium enhances growth of

Vijay Hemmadi, Randhir S Makkar, Jace W Jones, Christopher W Marshall, Allen R Place, Harold D May, Kevin R Sowers

Abstract read
In one paragraph

Article in Applied and environmental microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vijay HemmadiDepartment of Marine Biotechnology, Institute of Marine and Environmental Technology, University of Maryland Baltimore County, Baltimore, Maryland, USA.ORCID 0000-0002-8169-6817
Randhir S MakkarEnzylignol Inc, Ladson, South Carolina, USA.
Jace W JonesDepartment of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.ORCID 0000-0003-0460-0380
Christopher W MarshallDepartment of Biological Sciences, Marquette University, Milwaukee, Wisconsin, USA.ORCID 0000-0001-6669-3231
Allen R PlaceInstitute of Marine and Environmental Technology, University of Maryland Center for Environmental Sciences, Baltimore, Maryland, USA.ORCID 0000-0003-4692-2388
Harold D MayHollings Marine Laboratory, Medical University of South Carolina, Charleston, South Carolina, USA.ORCID 0000-0002-1873-0680
Kevin R SowersDepartment of Marine Biotechnology, Institute of Marine and Environmental Technology, University of Maryland Baltimore County, Baltimore, Maryland, USA.ORCID 0000-0002-8920-9278

Funding

Development of an innovative approach for in situ treatment of PCB impacted sediments by microbial bioremediationR44ES032365 · NIEHS · REMBAC ENVIRONMENTAL, LLC · PI AMOS, CRAIG BENNETT · 2023 to 2024
$1.1M
NIEHS NIH HHS R44 ES032365Office of Naval Research N000140610090Small Business Innovation Research 2R44ES032365University of Maryland School of Pharmacy Mass Spectrometry Center SOP1841-IQB2014
6 · The paper itself

Abstract

Polychlorinated biphenyls (PCBs) and chlorinated ethenes, such as perchloroethene (PCE), are persistent environmental contaminants that pose significant ecological and health risks.

Indexed as

Culture MediaEubacterialesGlycolipidsPolychlorinated BiphenylsTetrachloroethyleneBiodegradation, EnvironmentalBiosurfactantsCulture MediaGlycolipidsPolychlorinated BiphenylsrhamnolipidTetrachloroethylenebioremediationbiosurfactantsglycolipidsperchloroethenePseudodesulfovibrio sp.

Identifiers

PMID42544995
PMCPMC13488350

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.